Laverock Therapeutics's Logo

Laverock Therapeutics

Engineering Next-Generation Cell Therapies | Laverock Therapeutics

Who is Laverock Therapeutics?

Laverock's differentiated technology allows generation of products with improved efficacy, safety and accessibility, overcoming many of the limitations with existing approaches. These next-generation products are able to deliver directed, responsive activities ensuring favourable on- and off-target profiles.

This company is:

Manufacturer

Stevenage, United Kingdom

11-50 Employees

-



Products & services of Laverock Therapeutics

Product 
    
    Programmable Cell Therapies, CRISPR Gene Editing | Laverock Therapeutics
  
   image
Product

Verified

Programmable Cell Therapies, CRISPR Gene Editing | Laverock Therapeutics

Laverock Therapeutics’ mission is to engineer next-generation programmable cell therapies using advanced RNAi gene editing technology & bioinformatics

Product 
    
    Laverock Therapeutics secures Innovate UK funding
  
   image
Product

Verified

Laverock Therapeutics secures Innovate UK funding

Laverock Therapeutics secures Innovate UK award to advance immune effector cell therapeutics programme using GEiGS® technology | Laverock Therapeutics secures £1m funding via the Innovate UK Investor Partnerships Future Economy programme, supported by UKI2S.  | For further information please contact: | Notes to Editors | Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team | Exploring the convergence of gene editing and RNAi in iPSC-derived allogeneic cell therapy | Laverock Therapeutics to demonstrate breadth of therapeutic applications of gene silencing platform at ESGCT | Speak to one of our team

Product 
    
    Laverock Therapeutics raises £13.5M to develop unique gene silencing platform for programmable advanced therapies
  
   image
Product

Verified

Laverock Therapeutics raises £13.5M to develop unique gene silencing platform for programmable advanced therapies

Laverock Therapeutics raises £13.5M to develop unique gene silencing platform for programmable advanced therapies | For further information please contact: | Notes to Editors | Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team | Exploring the convergence of gene editing and RNAi in iPSC-derived allogeneic cell therapy | Laverock Therapeutics secures Innovate UK award to advance immune effector cell therapeutics programme using GEiGS® technology | Speak to one of our team

View all products


Keywords

Biotechnology

Industries

Biotechnology

Contact of Laverock Therapeutics

City: Stevenage

State: England

Country: United Kingdom



Frequently asked questions (FAQ) about Laverock Therapeutics

The company Laverock Therapeutics is located in Stevenage, England, United Kingdom. It's worth noting that the company may has more corporate locations

As of the latest available information Laverock Therapeutics has around 11-50 employees worldwide.

The company Laverock Therapeutics has it's main focus in the industries of Biotechnology